Your browser doesn't support javascript.
loading
Matrix metalloproteinase-2 plays a critical role in the pathogenesis of white matter lesions after chronic cerebral hypoperfusion in rodents.
Nakaji, Kayoko; Ihara, Masafumi; Takahashi, Chiaki; Itohara, Shigeyoshi; Noda, Makoto; Takahashi, Ryosuke; Tomimoto, Hidekazu.
Afiliación
  • Nakaji K; Department of Neurology, Kyoto University Graduate School of Medicine, Kyoto, Japan. kann@kuhp.kyoto-u.ac.jp
Stroke ; 37(11): 2816-23, 2006 Nov.
Article en En | MEDLINE | ID: mdl-17008622
BACKGROUND AND PURPOSE: Cerebrovascular white matter (WM) lesions contribute to cognitive impairment and motor dysfunction in the elderly. A disruption of the blood-brain barrier (BBB) is believed to be a critical early event leading to these WM lesions. Previous studies have suggested the involvement of matrix metalloproteinase-2 (MMP-2) in BBB disruptions and the upregulation of MMP-2 after chronic cerebral hypoperfusion in a rat model. In the present study, we asked whether MMP-2 is involved in the BBB disruption and the subsequent WM lesions after chronic cerebral hypoperfusion. METHODS: We compared the severity of white matter lesions in rats after chronic cerebral hypoperfusion with or without an MMP inhibitor. Then, we also induced the chronic cerebral hypoperfusion in wild-type and MMP-2-null mice. RESULTS: In the rats treated with a relatively selective MMP-2 inhibitor, AG3340, the WM lesions after chronic cerebral hypoperfusion were significantly less severe, and the number of activated astroglia and microglia were also significantly lower as compared with the vehicle-treated rats. Gene knockout of MMP-2 also reduced the severity of the WM lesions and the number of activated astroglia and microglia in a mice system. In both rodents, the disruption of BBB function, as assessed by IgM staining and the Evans blue extravasation test, was less severe when MMP-2 activity was attenuated. CONCLUSIONS: These findings indicate that MMP-2 plays a critical role in the BBB disruption, glial cell activation, and WM lesions after chronic cerebral hypoperfusion and suggest the potential value of MMP-2 inhibitors as a therapeutic tool in cerebrovascular WM lesions.
Asunto(s)
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Encéfalo / Daño Encefálico Crónico / Metaloproteinasa 2 de la Matriz / Fibras Nerviosas Mielínicas Tipo de estudio: Etiology_studies / Prognostic_studies Límite: Animals Idioma: En Revista: Stroke Año: 2006 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Estados Unidos
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Encéfalo / Daño Encefálico Crónico / Metaloproteinasa 2 de la Matriz / Fibras Nerviosas Mielínicas Tipo de estudio: Etiology_studies / Prognostic_studies Límite: Animals Idioma: En Revista: Stroke Año: 2006 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Estados Unidos